Unknown

Dataset Information

0

Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019.


ABSTRACT: World Health Organization (WHO) has prioritized the infectious emerging diseases such as Coronavirus Disease (COVID-19) in terms of research and development of effective tests, vaccines, antivirals, and other treatments. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), the etiological causative agent of COVID-19, is a virus belonging to risk group 3 that requires Biosafety Level (BSL)-3 laboratories and the corresponding facilities for handling. An alternative to these BSL-3/-4 laboratories is to use a pseudotyped virus that can be handled in a BSL-2 laboratory for study purposes. Recombinant Vesicular Stomatitis Virus (VSV) can be generated with complementary DNA from complete negative-stranded genomic RNA, with deleted G glycoprotein and, instead, incorporation of other fusion protein, like SARS-CoV-2 Spike (S protein). Accordingly, it is called pseudotyped VSV-SARS-CoV-2 S. In this review, we have described the generation of pseudotyped VSV with a focus on the optimization and application of pseudotyped VSV-SARS-CoV-2 S. The application of this pseudovirus has been addressed by its use in neutralizing antibody assays in order to evaluate a new vaccine, emergent SARS-CoV-2 variants (delta and omicron), and approved vaccine efficacy against variants of concern as well as in viral fusion-focused treatment analysis that can be performed under BSL-2 conditions.

SUBMITTER: Salazar-Garcia M 

PROVIDER: S-EPMC8795712 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC506966 | biostudies-literature
| S-EPMC7201057 | biostudies-literature
| S-EPMC7817443 | biostudies-literature
| S-EPMC7313936 | biostudies-literature
| S-EPMC3203393 | biostudies-literature
| S-EPMC6816421 | biostudies-literature
| S-EPMC7472544 | biostudies-literature
| S-EPMC4275776 | biostudies-literature
| PRJNA508804 | ENA
| S-EPMC8008698 | biostudies-literature